INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 257 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $156,311 | -38.5% | 4,094 | -33.8% | 0.00% | – |
| Q2 2023 | $254,295 | -45.8% | 6,187 | -24.3% | 0.00% | -100.0% |
| Q1 2023 | $469,207 | +3.3% | 8,174 | +1.0% | 0.00% | 0.0% |
| Q4 2022 | $454,345 | +64.6% | 8,091 | +24.2% | 0.00% | 0.0% |
| Q3 2022 | $276,000 | -28.9% | 6,514 | -9.6% | 0.00% | 0.0% |
| Q2 2022 | $388,000 | -43.4% | 7,204 | -4.6% | 0.00% | 0.0% |
| Q1 2022 | $685,000 | +43.0% | 7,555 | +5.3% | 0.00% | 0.0% |
| Q4 2021 | $479,000 | -5.3% | 7,174 | -2.7% | 0.00% | 0.0% |
| Q3 2021 | $506,000 | +2.6% | 7,376 | +2.4% | 0.00% | 0.0% |
| Q2 2021 | $493,000 | -1.2% | 7,201 | -0.1% | 0.00% | 0.0% |
| Q1 2021 | $499,000 | -7.6% | 7,208 | -13.2% | 0.00% | 0.0% |
| Q4 2020 | $540,000 | +37.1% | 8,307 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $394,000 | -76.5% | 8,378 | -76.5% | 0.00% | -83.3% |
| Q2 2020 | $1,679,000 | +2.8% | 35,701 | -2.5% | 0.01% | -14.3% |
| Q1 2020 | $1,634,000 | – | 36,618 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |